Report a data issue, formatting problem, or request follow-up. Our team responds within one business day.
Be the first to review this report.
Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products: 50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.
Global Botulinum Toxin A key players include Allergan (AGN), Ipsen, Merz Pharmaceuticals, etc.
United States is the largest market, with a share about 75%, followed by China, and Europe, both have a share about 20 percent.
In terms of product, 50iu is the largest segment, with a share about 60%. And in terms of application, the largest application is Medical Use, followed by Beauty Use.
This report provides an overview of the global Botulinum Toxin A market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Botulinum Toxin A and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Botulinum Toxin A revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Botulinum Toxin A market.
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Botulinum Toxin A industry.
Chapter 3: Detailed analysis of Botulinum Toxin A company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Botulinum Toxin A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Botulinum Toxin A in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
You may also be interested in
